IPG vs PRTA
IPG (IPG) versus Prothena Corporation plc (PRTA) — a side-by-side from cached financials, not a winner call.
IPG (IPG) common stock.
Prothena Corporation plc (PRTA) is a biotechnology company listed on US.
IPG does not have a complete income-statement cache yet.
Latest reported PRTA revenue for 2025-12-31 was $9.7M. Net income was -$244.1M. Revenue was down 92.8% from 2024-12-31 to 2025-12-31. PRTA currently screens at market cap $460.2M.
PRTA currently screens at market cap $460.2M.
Not investment advice. Open the IPG and PRTA stock pages for the full models.
Not investment advice.